New data from the American College of Cardiology’s CathPCI Registry reveal a steady but modest decline in contrast volume during percutaneous coronary interventions (PCI) between

Inflammation is reshaping cardiovascular disease evaluation, challenging cholesterol’s longtime dominance. Paul Ridker, MD, MPH, of Harvard Medical School and Brigham and Women’s Hospital, highlights the

Cardiovascular Associates of America (CVAUSA), a Florida-based private equity-backed cardiology management group, has partnered with HybridChart to deploy its advanced mobile rounding technology across all

A large real-world study from Italy suggests surgical aortic valve replacement (SAVR) offers better long-term survival than transcatheter aortic valve replacement (TAVR) for patients aged